表紙
市場調查報告書

青光眼治療藥的全球市場

Glaucoma Pharmaceuticals

出版商 Global Industry Analysts, Inc. 商品編碼 912740
出版日期 內容資訊 英文 252 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
青光眼治療藥的全球市場 Glaucoma Pharmaceuticals
出版日期: 2019年10月01日內容資訊: 英文 252 Pages
簡介

本報告提供全球青光眼治療藥市場相關調查分析,提供市場概要,主要企業,市場趨勢·促進因素,全球市場預測,各地區市場分析,競爭情形相關的系統性資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 全球市場的企業佔有率
    • 全球市場的企業佔有率方案
  • 主要企業
  • 市場趨勢與發展因素
  • 全球市場預測
    • 全球市場的估計·預測:各區各國
    • 全球市場方案:各區各國
    • 市場佔有率的轉變:各地區
    • 各最終用途
      • 醫院
      • 眼科診所
      • ASC (外科門診診療所)
    • 各類藥物
      • 前列腺素
      • β受體阻斷劑
      • Alpha促效劑
      • 碳酸酐酵素抑制劑
      • 並用藥
      • 膽鹼促效劑

第3章 市場分析

  • 地區市場分析
  • 美國
    • 市場概要
    • 市場佔有率:各企業
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲各國
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他的亞太地區
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美地區
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競爭企業

  • AERIE PHARMACEUTICALS
  • ALLERGAN PLC
  • MERCK & CO., INC.
  • NOVARTIS INTERNATIONAL AG
  • PFIZER
  • SANTEN PHARMACEUTICAL

第5章 調查資料

目錄
Product Code: MCP-6268

Glaucoma Pharmaceuticals market worldwide is projected to grow by US$1.3 Billion, driven by a compounded growth of 3%. Hospitals, one of the segments analyzed and sized in this study, displays the potential to grow at over 3.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$4.4 Billion by the year 2025, Hospitals will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 2.3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$50.8 Million to the region's size and clout in the next 5 to 6 years. Over US$40.2 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Hospitals will reach a market size of US$263.6 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 4.5% over the next couple of years and add approximately US$361.9 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, Aerie Pharmaceuticals, Inc.; Allergan PLC; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.; Santen Pharmaceuticals Co., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Glaucoma Pharmaceuticals Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Glaucoma Pharmaceuticals Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Glaucoma Pharmaceuticals Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Glaucoma Pharmaceuticals Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Hospitals (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025
  • TABLE 5: Hospitals (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 6: Hospitals (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Ophthalmic Clinics (End-Use) Worldwide Sales in US$ Million by Region/Country: 2018-2025
  • TABLE 8: Ophthalmic Clinics (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017
  • TABLE 9: Ophthalmic Clinics (End-Use) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025
  • TABLE 10: Ambulatory Surgical Centers (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 11: Ambulatory Surgical Centers (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 12: Ambulatory Surgical Centers (End-Use) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Prostaglandins (Drug Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: Prostaglandins (Drug Class) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Prostaglandins (Drug Class) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Beta Blockers (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 17: Beta Blockers (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 18: Beta Blockers (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Alpha Agonists (Drug Class) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
  • TABLE 20: Alpha Agonists (Drug Class) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 21: Alpha Agonists (Drug Class) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 22: Carbonic Anhydrase Inhibitors (Drug Class) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025
  • TABLE 23: Carbonic Anhydrase Inhibitors (Drug Class) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017
  • TABLE 24: Carbonic Anhydrase Inhibitors (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 25: Combination Medications (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 26: Combination Medications (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 27: Combination Medications (Drug Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 28: Cholinergics (Drug Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 29: Cholinergics (Drug Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 30: Cholinergics (Drug Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Glaucoma Pharmaceuticals Market Share (in %) by Company: 2019 & 2025
    • TABLE 31: United States Glaucoma Pharmaceuticals Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
    • TABLE 32: Glaucoma Pharmaceuticals Historic Demand Patterns in the United States by End-Use in US$ Million for 2009-2017
    • TABLE 33: Glaucoma Pharmaceuticals Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025
    • TABLE 34: United States Glaucoma Pharmaceuticals Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 35: Glaucoma Pharmaceuticals Market in the United States by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 36: United States Glaucoma Pharmaceuticals Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 37: Canadian Glaucoma Pharmaceuticals Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
    • TABLE 38: Glaucoma Pharmaceuticals Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
    • TABLE 39: Canadian Glaucoma Pharmaceuticals Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
    • TABLE 40: Canadian Glaucoma Pharmaceuticals Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 41: Canadian Glaucoma Pharmaceuticals Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 42: Glaucoma Pharmaceuticals Market in Canada: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • JAPAN
    • TABLE 43: Japanese Demand Estimates and Forecasts for Glaucoma Pharmaceuticals in US$ Million by End-Use: 2018 to 2025
    • TABLE 44: Japanese Glaucoma Pharmaceuticals Market in US$ Million by End-Use: 2009-2017
    • TABLE 45: Glaucoma Pharmaceuticals Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025
    • TABLE 46: Japanese Market for Glaucoma Pharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 47: Glaucoma Pharmaceuticals Market in Japan: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 48: Japanese Glaucoma Pharmaceuticals Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 49: Chinese Demand for Glaucoma Pharmaceuticals in US$ Million by End-Use: 2018 to 2025
    • TABLE 50: Glaucoma Pharmaceuticals Market Review in China in US$ Million by End-Use: 2009-2017
    • TABLE 51: Chinese Glaucoma Pharmaceuticals Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
    • TABLE 52: Chinese Glaucoma Pharmaceuticals Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 53: Glaucoma Pharmaceuticals Historic Market Analysis in China in US$ Million by Drug Class: 2009-2017
    • TABLE 54: Chinese Glaucoma Pharmaceuticals Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Glaucoma Pharmaceuticals Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 55: European Glaucoma Pharmaceuticals Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 56: Glaucoma Pharmaceuticals Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 57: European Glaucoma Pharmaceuticals Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 58: European Glaucoma Pharmaceuticals Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
    • TABLE 59: Glaucoma Pharmaceuticals Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
    • TABLE 60: European Glaucoma Pharmaceuticals Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
    • TABLE 61: European Glaucoma Pharmaceuticals Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 62: Glaucoma Pharmaceuticals Market in Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 63: European Glaucoma Pharmaceuticals Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 64: Glaucoma Pharmaceuticals Quantitative Demand Analysis in France in US$ Million by End-Use: 2018-2025
    • TABLE 65: French Glaucoma Pharmaceuticals Historic Market Review in US$ Million by End-Use: 2009-2017
    • TABLE 66: French Glaucoma Pharmaceuticals Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
    • TABLE 67: Glaucoma Pharmaceuticals Market in France by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 68: French Glaucoma Pharmaceuticals Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 69: French Glaucoma Pharmaceuticals Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 70: Glaucoma Pharmaceuticals Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025
    • TABLE 71: German Glaucoma Pharmaceuticals Market in Retrospect in US$ Million by End-Use: 2009-2017
    • TABLE 72: Glaucoma Pharmaceuticals Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025
    • TABLE 73: Glaucoma Pharmaceuticals Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 74: German Glaucoma Pharmaceuticals Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 75: German Glaucoma Pharmaceuticals Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 76: Italian Demand for Glaucoma Pharmaceuticals in US$ Million by End-Use: 2018 to 2025
    • TABLE 77: Glaucoma Pharmaceuticals Market Review in Italy in US$ Million by End-Use: 2009-2017
    • TABLE 78: Italian Glaucoma Pharmaceuticals Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
    • TABLE 79: Italian Glaucoma Pharmaceuticals Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 80: Glaucoma Pharmaceuticals Historic Market Analysis in Italy in US$ Million by Drug Class: 2009-2017
    • TABLE 81: Italian Glaucoma Pharmaceuticals Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 82: United Kingdom Demand Estimates and Forecasts for Glaucoma Pharmaceuticals in US$ Million by End-Use: 2018 to 2025
    • TABLE 83: United Kingdom Glaucoma Pharmaceuticals Market in US$ Million by End-Use: 2009-2017
    • TABLE 84: Glaucoma Pharmaceuticals Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025
    • TABLE 85: United Kingdom Market for Glaucoma Pharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 86: Glaucoma Pharmaceuticals Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 87: United Kingdom Glaucoma Pharmaceuticals Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 88: Spanish Glaucoma Pharmaceuticals Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
    • TABLE 89: Glaucoma Pharmaceuticals Market in Spain: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
    • TABLE 90: Spanish Glaucoma Pharmaceuticals Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
    • TABLE 91: Spanish Glaucoma Pharmaceuticals Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 92: Spanish Glaucoma Pharmaceuticals Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 93: Glaucoma Pharmaceuticals Market in Spain: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 94: Russian Glaucoma Pharmaceuticals Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
    • TABLE 95: Glaucoma Pharmaceuticals Historic Demand Patterns in Russia by End-Use in US$ Million for 2009-2017
    • TABLE 96: Glaucoma Pharmaceuticals Market Share Breakdown in Russia by End-Use: 2009 VS 2019 VS 2025
    • TABLE 97: Russian Glaucoma Pharmaceuticals Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 98: Glaucoma Pharmaceuticals Market in Russia by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 99: Russian Glaucoma Pharmaceuticals Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 100: Rest of Europe Glaucoma Pharmaceuticals Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
    • TABLE 101: Glaucoma Pharmaceuticals Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
    • TABLE 102: Rest of Europe Glaucoma Pharmaceuticals Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
    • TABLE 103: Rest of Europe Glaucoma Pharmaceuticals Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 104: Glaucoma Pharmaceuticals Market in Rest of Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 105: Rest of Europe Glaucoma Pharmaceuticals Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 106: Asia-Pacific Glaucoma Pharmaceuticals Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 107: Glaucoma Pharmaceuticals Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 108: Asia-Pacific Glaucoma Pharmaceuticals Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 109: Glaucoma Pharmaceuticals Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025
    • TABLE 110: Asia-Pacific Glaucoma Pharmaceuticals Historic Market Review in US$ Million by End-Use: 2009-2017
    • TABLE 111: Asia-Pacific Glaucoma Pharmaceuticals Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
    • TABLE 112: Glaucoma Pharmaceuticals Market in Asia-Pacific by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 113: Asia-Pacific Glaucoma Pharmaceuticals Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 114: Asia-Pacific Glaucoma Pharmaceuticals Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 115: Glaucoma Pharmaceuticals Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025
    • TABLE 116: Australian Glaucoma Pharmaceuticals Market in Retrospect in US$ Million by End-Use: 2009-2017
    • TABLE 117: Glaucoma Pharmaceuticals Market Share Distribution in Australia by End-Use: 2009 VS 2019 VS 2025
    • TABLE 118: Glaucoma Pharmaceuticals Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 119: Australian Glaucoma Pharmaceuticals Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 120: Australian Glaucoma Pharmaceuticals Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 121: Indian Glaucoma Pharmaceuticals Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
    • TABLE 122: Glaucoma Pharmaceuticals Market in India: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
    • TABLE 123: Indian Glaucoma Pharmaceuticals Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
    • TABLE 124: Indian Glaucoma Pharmaceuticals Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 125: Indian Glaucoma Pharmaceuticals Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 126: Glaucoma Pharmaceuticals Market in India: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 127: Glaucoma Pharmaceuticals Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2018-2025
    • TABLE 128: South Korean Glaucoma Pharmaceuticals Historic Market Analysis in US$ Million by End-Use: 2009-2017
    • TABLE 129: Glaucoma Pharmaceuticals Market Share Distribution in South Korea by End-Use: 2009 VS 2019 VS 2025
    • TABLE 130: Glaucoma Pharmaceuticals Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 131: South Korean Glaucoma Pharmaceuticals Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 132: Glaucoma Pharmaceuticals Market Share Distribution in South Korea by Drug Class: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 133: Rest of Asia-Pacific Demand Estimates and Forecasts for Glaucoma Pharmaceuticals in US$ Million by End-Use: 2018 to 2025
    • TABLE 134: Rest of Asia-Pacific Glaucoma Pharmaceuticals Market in US$ Million by End-Use: 2009-2017
    • TABLE 135: Glaucoma Pharmaceuticals Market Share Shift in Rest of Asia-Pacific by End-Use: 2009 VS 2019 VS 2025
    • TABLE 136: Rest of Asia-Pacific Market for Glaucoma Pharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 137: Glaucoma Pharmaceuticals Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 138: Rest of Asia-Pacific Glaucoma Pharmaceuticals Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 139: Latin American Glaucoma Pharmaceuticals Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 140: Glaucoma Pharmaceuticals Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 141: Latin American Glaucoma Pharmaceuticals Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 142: Latin American Demand for Glaucoma Pharmaceuticals in US$ Million by End-Use: 2018 to 2025
    • TABLE 143: Glaucoma Pharmaceuticals Market Review in Latin America in US$ Million by End-Use: 2009-2017
    • TABLE 144: Latin American Glaucoma Pharmaceuticals Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
    • TABLE 145: Latin American Glaucoma Pharmaceuticals Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 146: Glaucoma Pharmaceuticals Historic Market Analysis in Latin America in US$ Million by Drug Class: 2009-2017
    • TABLE 147: Latin American Glaucoma Pharmaceuticals Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 148: Argentinean Glaucoma Pharmaceuticals Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
    • TABLE 149: Glaucoma Pharmaceuticals Market in Argentina: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
    • TABLE 150: Argentinean Glaucoma Pharmaceuticals Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
    • TABLE 151: Argentinean Glaucoma Pharmaceuticals Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 152: Glaucoma Pharmaceuticals Market in Argentina in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 153: Argentinean Glaucoma Pharmaceuticals Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 154: Glaucoma Pharmaceuticals Quantitative Demand Analysis in Brazil in US$ Million by End-Use: 2018-2025
    • TABLE 155: Brazilian Glaucoma Pharmaceuticals Historic Market Review in US$ Million by End-Use: 2009-2017
    • TABLE 156: Brazilian Glaucoma Pharmaceuticals Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
    • TABLE 157: Glaucoma Pharmaceuticals Market in Brazil by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 158: Brazilian Glaucoma Pharmaceuticals Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 159: Brazilian Glaucoma Pharmaceuticals Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 160: Glaucoma Pharmaceuticals Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025
    • TABLE 161: Mexican Glaucoma Pharmaceuticals Market in Retrospect in US$ Million by End-Use: 2009-2017
    • TABLE 162: Glaucoma Pharmaceuticals Market Share Distribution in Mexico by End-Use: 2009 VS 2019 VS 2025
    • TABLE 163: Glaucoma Pharmaceuticals Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 164: Mexican Glaucoma Pharmaceuticals Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 165: Mexican Glaucoma Pharmaceuticals Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 166: Rest of Latin America Glaucoma Pharmaceuticals Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
    • TABLE 167: Glaucoma Pharmaceuticals Historic Demand Patterns in Rest of Latin America by End-Use in US$ Million for 2009-2017
    • TABLE 168: Glaucoma Pharmaceuticals Market Share Breakdown in Rest of Latin America by End-Use: 2009 VS 2019 VS 2025
    • TABLE 169: Rest of Latin America Glaucoma Pharmaceuticals Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 170: Glaucoma Pharmaceuticals Market in Rest of Latin America by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 171: Rest of Latin America Glaucoma Pharmaceuticals Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 172: The Middle East Glaucoma Pharmaceuticals Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 173: Glaucoma Pharmaceuticals Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 174: The Middle East Glaucoma Pharmaceuticals Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 175: The Middle East Glaucoma Pharmaceuticals Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
    • TABLE 176: Glaucoma Pharmaceuticals Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
    • TABLE 177: The Middle East Glaucoma Pharmaceuticals Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
    • TABLE 178: The Middle East Glaucoma Pharmaceuticals Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 179: The Middle East Glaucoma Pharmaceuticals Historic Market by Drug Class in US$ Million: 2009-2017
    • TABLE 180: Glaucoma Pharmaceuticals Market in the Middle East: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • IRAN
    • TABLE 181: Iranian Demand Estimates and Forecasts for Glaucoma Pharmaceuticals in US$ Million by End-Use: 2018 to 2025
    • TABLE 182: Iranian Glaucoma Pharmaceuticals Market in US$ Million by End-Use: 2009-2017
    • TABLE 183: Glaucoma Pharmaceuticals Market Share Shift in Iran by End-Use: 2009 VS 2019 VS 2025
    • TABLE 184: Iranian Market for Glaucoma Pharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 185: Glaucoma Pharmaceuticals Market in Iran: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 186: Iranian Glaucoma Pharmaceuticals Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 187: Israeli Glaucoma Pharmaceuticals Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
    • TABLE 188: Glaucoma Pharmaceuticals Market in Israel: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
    • TABLE 189: Israeli Glaucoma Pharmaceuticals Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
    • TABLE 190: Israeli Glaucoma Pharmaceuticals Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 191: Glaucoma Pharmaceuticals Market in Israel in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 192: Israeli Glaucoma Pharmaceuticals Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 193: Saudi Arabian Demand for Glaucoma Pharmaceuticals in US$ Million by End-Use: 2018 to 2025
    • TABLE 194: Glaucoma Pharmaceuticals Market Review in Saudi Arabia in US$ Million by End-Use: 2009-2017
    • TABLE 195: Saudi Arabian Glaucoma Pharmaceuticals Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
    • TABLE 196: Saudi Arabian Glaucoma Pharmaceuticals Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 197: Glaucoma Pharmaceuticals Historic Market Analysis in Saudi Arabia in US$ Million by Drug Class: 2009-2017
    • TABLE 198: Saudi Arabian Glaucoma Pharmaceuticals Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 199: Glaucoma Pharmaceuticals Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2018-2025
    • TABLE 200: United Arab Emirates Glaucoma Pharmaceuticals Historic Market Analysis in US$ Million by End-Use: 2009-2017
    • TABLE 201: Glaucoma Pharmaceuticals Market Share Distribution in United Arab Emirates by End-Use: 2009 VS 2019 VS 2025
    • TABLE 202: Glaucoma Pharmaceuticals Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 203: United Arab Emirates Glaucoma Pharmaceuticals Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 204: Glaucoma Pharmaceuticals Market Share Distribution in United Arab Emirates by Drug Class: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 205: Glaucoma Pharmaceuticals Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025
    • TABLE 206: Rest of Middle East Glaucoma Pharmaceuticals Market in Retrospect in US$ Million by End-Use: 2009-2017
    • TABLE 207: Glaucoma Pharmaceuticals Market Share Distribution in Rest of Middle East by End-Use: 2009 VS 2019 VS 2025
    • TABLE 208: Glaucoma Pharmaceuticals Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 209: Rest of Middle East Glaucoma Pharmaceuticals Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 210: Rest of Middle East Glaucoma Pharmaceuticals Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 211: African Glaucoma Pharmaceuticals Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
    • TABLE 212: Glaucoma Pharmaceuticals Historic Demand Patterns in Africa by End-Use in US$ Million for 2009-2017
    • TABLE 213: Glaucoma Pharmaceuticals Market Share Breakdown in Africa by End-Use: 2009 VS 2019 VS 2025
    • TABLE 214: African Glaucoma Pharmaceuticals Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 215: Glaucoma Pharmaceuticals Market in Africa by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 216: African Glaucoma Pharmaceuticals Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

IV. COMPETITION

  • AERIE PHARMACEUTICALS
  • ALLERGAN PLC
  • MERCK & CO., INC.
  • NOVARTIS INTERNATIONAL AG
  • PFIZER
  • SANTEN PHARMACEUTICAL

V. CURATED RESEARCH

Back to Top